These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 21643487)
21. Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2. Wullner U; Neef I; Eller A; Kleines M; Tur MK; Barth S Curr Cancer Drug Targets; 2008 Nov; 8(7):554-65. PubMed ID: 18991566 [TBL] [Abstract][Full Text] [Related]
22. In Silico Selection of Gp120 ssDNA Aptamer to HIV-1. Sepehri Zarandi H; Behbahani M; Mohabatkar H SLAS Discov; 2020 Oct; 25(9):1087-1093. PubMed ID: 32452249 [TBL] [Abstract][Full Text] [Related]
23. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents. Kim M; Kim DM; Kim KS; Jung W; Kim DE Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327 [TBL] [Abstract][Full Text] [Related]
24. Small Interfering RNAs and their Delivery Systems: A Novel Powerful Tool for the Potential Treatment of HIV Infections. Bolhassani A; Milani A Curr Mol Pharmacol; 2020; 13(3):173-181. PubMed ID: 31760929 [TBL] [Abstract][Full Text] [Related]
25. Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. Fattal E; Bochot A Adv Drug Deliv Rev; 2006 Nov; 58(11):1203-23. PubMed ID: 17097190 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras. Wheeler LA; Trifonova R; Vrbanac V; Basar E; McKernan S; Xu Z; Seung E; Deruaz M; Dudek T; Einarsson JI; Yang L; Allen TM; Luster AD; Tager AM; Dykxhoorn DM; Lieberman J J Clin Invest; 2011 Jun; 121(6):2401-12. PubMed ID: 21576818 [TBL] [Abstract][Full Text] [Related]
27. Blocking interaction of viral gp120 and CD4-expressing T cells by single-stranded DNA aptamers. Zhao N; Pei SN; Parekh P; Salazar E; Zu Y Int J Biochem Cell Biol; 2014 Jun; 51():10-8. PubMed ID: 24661998 [TBL] [Abstract][Full Text] [Related]
31. Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer. de Almeida CEB; Alves LN; Rocha HF; Cabral-Neto JB; Missailidis S Int J Pharm; 2017 Jun; 525(2):334-342. PubMed ID: 28373101 [TBL] [Abstract][Full Text] [Related]
32. Targeted delivery of short interfering RNAs--strategies for in vivo delivery. Wullner U; Neef I; Tur MK; Barth S Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):1-8. PubMed ID: 19149683 [TBL] [Abstract][Full Text] [Related]
33. Multivalent comb-type aptamer-siRNA conjugates for efficient and selective intracellular delivery. Yoo H; Jung H; Kim SA; Mok H Chem Commun (Camb); 2014 Jun; 50(51):6765-7. PubMed ID: 24830507 [TBL] [Abstract][Full Text] [Related]
39. Rabies Prophylactic and Treatment Options: An In Vitro Study of siRNA- and Aptamer-Based Therapeutics. Scott TP; Nel LH Viruses; 2021 May; 13(5):. PubMed ID: 34064911 [TBL] [Abstract][Full Text] [Related]
40. The aptamer-siRNA conjugates: reprogramming T cells for cancer therapy. Sakib Hossain DM; Duttagupta P; Kortylewski M Ther Deliv; 2015 Jan; 6(1):1-4. PubMed ID: 25565435 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]